Xi Kathy Zhou

Weill Medical Coll Of Cornell Univ

$565,366

Attributed

$849,314

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $237.7K · FY2009–24

$250K$187.5K$125K$62.5K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$849,314 · 2

By mechanism

R21$849,314 · 2

Top collaborators

Irina Matei2 shared
Melody Y Zeng2 shared

Most similar at Weill Medical Coll Of Cornell Univ

Same institution · by research overlap

Others in their field

Top investigators on “Cancer Therapy”

David Heimbrook · Leidos Biomedical Research, Inc.$366,127,178
Norman Wolmark · Nsabp Foundation, Inc.$292,963,206
Gregory H Reaman · National Childhood Cancer Foundation$271,061,526
Peter C Adamson · National Childhood Cancer Foundation$269,808,480
Charles A Coltman · Southwest Oncology Group$178,303,465
Sudhir Raju · Ctis, Inc.$162,436,462

Research focus

Cancer TherapyElderlyAdaptive Immune ResponseAffinityAnimal FacilityAnimal ModelAnti-Tumor Immune ResponseCancer ControlAntitumor ResponseAreaBaseB Cell RepertoireB-LymphocytesB-Lymphocyte SubsetsCancer BiomarkersAntibodiesCancer ImmunotherapyCancer ModelCancer PatientCancer PrognosisAffectCaringCell CommunicationAccounting

Grant awards (4)

Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis$188,198

R21 · FY2024 · CA

Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis$237,724

R21 · FY2023 · CA

Comprehensive Prognostic Modeling for Esophageal Cancer: A Bayesian Approach$225,553

R21 · FY2010 · CA · contact PI

Comprehensive Prognostic Modeling for Esophageal Cancer: A Bayesian Approach$197,839

R21 · FY2009 · CA · contact PI